IL18 and neoplasm: We have previously demonstrated that a mature-IL-18 expression vector with the Igκ leader sequence is useful for construction of clones that secrete a large amount of bioactive IL-18 and that IL-18-secreting tumor cells can elicit a specific antitumor immune response via the infiltration of CD4+ T cells and CD8+T cells (9).